Developed on: August 2020
Developed by: MRCT Center Diversity Workgroup
There are practical and operational barriers that prevent routine participation of underrepresented, underserved, and diverse populations in clinical research. These must be addressed to promote change. While many challenges exist, for each section, we provide a key summary and recommendations to address appropriate representation in clinical research. Link to Resource >
Comments provided on: July 20, 2020
Comments provided to: Food and Drug Administration (FDA)
Comments provided on: June 29, 2020
Comments provided to: Food and Drug Administration (FDA)
Presented on: June 18, 2020
Presented by: Barbara E. Bierer, MD
Presented at: DIA 2020 Virtual Global Annual Meeting
Presented on: June 18, 2020
Presented by: Sylvia Baedorf Kassis
Presented at: DIA 2020 Virtual Global Annual Meeting
Published on: January 20, 2020
Published in: Journal of Clinical Epidemiology
Comments provided on: April 29, 2020
Comments provided to : European Commission
Presented on: April 17, 2020
Presented by: Sylvia Baedorf Kassis
Presented at: Tufts University School of Medicine Plain Language Workshop
Published on: March 20, 2020
Published in: Science
Published on: March 2, 2020
Published in: European Journal of Human Genetics
